Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

Seton Hall-Hackensack Meridian School of Medicine

Seton Hall-Hackensack-Meridian School of Medicine’s Dean Bonita Stanton to Be Honored by Tri-County Scholarship Fund on November 6

Dean Bonita Stanton

Whippany, NJ, October 27, 2017 — Michael Ricciardelli reports that Dr. Bonita Stanton, founding dean of the Seton Hall-Hackensack-Meridian School of Medicine, has been honored by the Tri-County Scholarship Fund.

Dean Stanton’s award will be presented at the Fund’s 36th annual Gala Awards Dinner at the Hanover Marriott in Whippany, celebrating more than three decades of helping financially needy students in Morris, Passaic and Sussex counties on November 6, 2017.

The mission of Tri-County Scholarship Fund is to provide financial support for deserving students to obtain a quality, values-based education in accredited private elementary and secondary schools. Continue reading

Hackensack University Medical Center Foundation Receives Donation from Celgene to Advance Multiple Myeloma Research at John Theurer Cancer Center

Former Roche campus to be new Seton Hall-Hackensack Meridian School of Medicine

Hackensack, NJ, October 20, 2017 — The Hackensack University Medical Center Foundation announced on October 5 that it has received a substantial donation from Celgene Corporation to advance multiple myeloma research and transformational medicine that improve patient outcomes at Hackensack Meridian Health–John Theurer Cancer Center.

Supported by Celgene, a global biopharmaceutical leader in the discovery, development and delivery of treatment for diseases like multiple myeloma (MM), funds will help to establish the Multiple Myeloma Institute (MMI) — a leading-edge research facility at the Seton Hall-Hackensack Meridian School of Medicine scheduled to open in 2018.

Celgene and John Theurer Cancer Center are accomplished leaders in developing novel therapies for patients with multiple myeloma. Continue reading

Hackensack University Medical Center Foundation Receives Donation from Celgene to Advance Multiple Myeloma Research at John Theurer Cancer Center

Former Roche campus to be new Seton Hall-Hackensack Meridian School of Medicine

Hackensack, NJ, October 11, 2017 — The Hackensack University Medical Center Foundation announced on October 5 that it has received a substantial donation from Celgene Corporation to advance multiple myeloma research and transformational medicine that improve patient outcomes at Hackensack Meridian Health–John Theurer Cancer Center.

Supported by Celgene, a global biopharmaceutical leader in the discovery, development and delivery of treatment for diseases like multiple myeloma (MM), funds will help to establish the Multiple Myeloma Institute (MMI) — a leading-edge research facility at the Seton Hall-Hackensack Meridian School of Medicine scheduled to open in 2018.

Celgene and John Theurer Cancer Center are accomplished leaders in developing novel therapies for patients with multiple myeloma. Continue reading

Robert and Laura Garrett Gift $2.65 Million to Endow Seton Hall-Hackensack Meridian Med School Dean’s Post

Robert and Laura Garrett

Hackensack, NJ, August 3, 2017 — Anjalee Khemlani reports in NJBIZ that Hackensack Meridian Health co-CEO Robert Garrett and his wife, Laura Garrett, have provided a $2.65 million gift in honor of the new Seton Hall-Hackensack Meridian School of Medicine’s founding dean, Dr. Bonita Stanton.

Dr. Stanton was appointed to the Robert C. and Laura C. Garrett Endowed Chair for the School of Medicine Dean.

“Endowed chairs are among the highest honors conferred in academia, and the $15 million in support of endowments at Hackensack University Medical Center reinforces its role as one of the top-ranked academic medical centers in the country,” the health system said in a statement. Continue reading

Ex-Roche Campus Reinvented as ‘On3’ Science Center; Developer Seeks to Create Mini-Metropolis in the Suburbs’ for Life Sciences

Nutley, NJ, June 23, 2017 — Owen Proctor reports in The Record/NorthJersey.com that the former Hoffmann-La Roche campus that borders Clifton and Nutley has a new name.

“On3” seeks to incorporate living, working and playing in the Route 3 site, according to Prism Capital Partners’ principal Eugene Diaz. He described the redevelopment as “a mini-metropolis in the suburbs.”

The firm wants to reinvent the 116-acre campus that the pharmaceutical giant began vacating in 2012, creating a synergy among like-minded businesses geared toward life sciences. Continue reading

Seton Hall-Hackensack Meridian School of Medicine Dean Bonita Stanton Featured in ‘Industry Magazine’

Dr. Bonita Stanton

South Orange, NJ, June 21, 2017 — Dean Bonita Stanton, M.D., of the Seton Hall-Hackensack Meridian School of Medicine was interviewed and featured in the June 2017 issue of Industry Magazine.

The article, “Healthcare’s Horizon,” explores the new School of Medicine as a shift in paradigm for both medical pedagogy and health care delivery.

Noting how “The anticipated Seton Hall-Hackensack Meridian School of Medicine will offer an innovative team-based approach that will mirror how healthcare will be delivered in the future,” the article begins: Continue reading